31.41
price down icon4.67%   -1.54
after-market Dopo l'orario di chiusura: 31.41
loading

Q 32 Bio Inc Borsa (QTTB) Ultime notizie

pulisher
Nov 08, 2024

Q32 Bio Advances Clinical Trials Amidst Financial Challenges - TipRanks

Nov 08, 2024
pulisher
Nov 08, 2024

Q32 Bio Inc Grapples with Internal Control Challenges Amid Compliance Costs - TipRanks

Nov 08, 2024
pulisher
Nov 07, 2024

Q32 Bio: Q3 Earnings Snapshot - Milford Mirror

Nov 07, 2024
pulisher
Nov 07, 2024

Q32 Bio Reports Third Quarter 2024 Financial Results and Provides Corporate Update - citybiz

Nov 07, 2024
pulisher
Nov 07, 2024

Q32 Bio Inc. (QTTB) Quarterly 10-Q Report - Quartzy

Nov 07, 2024
pulisher
Nov 07, 2024

Q32 Bio reports Q3 EPS ($1.46), consensus ($1.40) - TipRanks

Nov 07, 2024
pulisher
Nov 05, 2024

Q32 Bio to Present at Guggenheim's First Healthcare Innovation Conference | QTTB | QTTB Stock News - StockTitan

Nov 05, 2024
pulisher
Nov 03, 2024

Brokerages Set Q32 Bio Inc. (NASDAQ:QTTB) Target Price at $72.33 - Defense World

Nov 03, 2024
pulisher
Oct 28, 2024

Q32 Bio (NASDAQ:QTTB) Shares Down 3.6%Time to Sell? - MarketBeat

Oct 28, 2024
pulisher
Oct 28, 2024

Complement Inhibitors Clinical Trial Pipeline Analysis: 40+ - GlobeNewswire

Oct 28, 2024
pulisher
Oct 28, 2024

Complement Inhibitors Clinical Trial Pipeline Analysis: 40+ Key Companies Shaping the Future of Complement Inhibitor Therapeutics | DelveInsight - India Shorts

Oct 28, 2024
pulisher
Oct 27, 2024

Q32 Bio (NASDAQ:QTTB) Stock Price Up 5% – Here’s Why - Defense World

Oct 27, 2024
pulisher
Oct 25, 2024

Q32 Bio (NASDAQ:QTTB) Stock Price Up 5%Here's What Happened - MarketBeat

Oct 25, 2024
pulisher
Oct 24, 2024

Raymond James Initiates Coverage of Q32 Bio (QTTB) with Strong Buy Recommendation - MSN

Oct 24, 2024
pulisher
Oct 24, 2024

Q32 Bio (NASDAQ:QTTB) Research Coverage Started at Raymond James - MarketBeat

Oct 24, 2024
pulisher
Oct 24, 2024

Upstream Bio stock rallies 32% following upsized $255M IPO - MSN

Oct 24, 2024
pulisher
Oct 16, 2024

Oppenheimer Maintains Bullish Stance on Q32 Bio with Robust Clinical Outlook - Yahoo Finance

Oct 16, 2024
pulisher
Oct 16, 2024

Oppenheimer Maintains Bullish Stance on Q32 Bio with Robust Clin - GuruFocus.com

Oct 16, 2024
pulisher
Oct 16, 2024

ADX-097, potential AAV therapy, fares well in healthy volunteers - ANCA Vasculitis News

Oct 16, 2024
pulisher
Oct 16, 2024

Oppenheimer holds stock target, upbeat on Q32 Bio ahead of data - Investing.com

Oct 16, 2024
pulisher
Oct 16, 2024

Oppenheimer holds stock target, upbeat on Q32 Bio ahead of data By Investing.com - Investing.com South Africa

Oct 16, 2024
pulisher
Oct 14, 2024

Q32 Bio to Present Tissue-Targeted Complement Inhibitor ADX-097 Positive Phase 1 Clinical Trial Results at the American Society of Nephrology Kidney Week 2024 - cnhinews.com

Oct 14, 2024
pulisher
Oct 13, 2024

Renaissance Technologies LLC Buys 685,151 Shares of GlycoMimetics, Inc. (NASDAQ:GLYC) - Defense World

Oct 13, 2024
pulisher
Oct 13, 2024

Renaissance Technologies LLC Decreases Stock Position in Sana Biotechnology, Inc. (NASDAQ:SANA) - Defense World

Oct 13, 2024
pulisher
Oct 13, 2024

Citizens Community Bancorp, Inc. (NASDAQ:CZWI) Shares Sold by Renaissance Technologies LLC - Defense World

Oct 13, 2024
pulisher
Oct 13, 2024

Renaissance Technologies LLC Grows Stock Holdings in OptimumBank Holdings, Inc. (NASDAQ:OPHC) - Defense World

Oct 13, 2024
pulisher
Oct 13, 2024

Renaissance Technologies LLC Acquires Shares of 66,500 Waldencast plc (NASDAQ:WALD) - Defense World

Oct 13, 2024
pulisher
Oct 13, 2024

Renaissance Technologies LLC Takes $265,000 Position in Q32 Bio Inc. (NASDAQ:QTTB) - MarketBeat

Oct 13, 2024
pulisher
Oct 13, 2024

Renaissance Technologies LLC Buys Shares of 84,300 Metalla Royalty & Streaming Ltd. (NYSEMKT:MTA) - Defense World

Oct 13, 2024
pulisher
Oct 11, 2024

We went to a startup symposium at the University of Colorado. We saw these nine cool startups. We said "wow" a lot. - Colorado Public Radio

Oct 11, 2024
pulisher
Oct 10, 2024

private equity firms who own 52% along with institutions invested in Q32 Bio Inc. (NASDAQ:QTTB) saw increase in their holdings value last week - Simply Wall St

Oct 10, 2024
pulisher
Oct 08, 2024

Q32 Bio (NASDAQ:QTTB) Shares Up 4.8% – What’s Next? - Defense World

Oct 08, 2024
pulisher
Oct 08, 2024

Q32 Bio (NASDAQ:QTTB) Stock Price Up 4.8%What's Next? - MarketBeat

Oct 08, 2024
pulisher
Oct 06, 2024

Analysts Set Q32 Bio Inc. (NASDAQ:QTTB) PT at $68.80 - MarketBeat

Oct 06, 2024
pulisher
Oct 01, 2024

Q32 Bio Inc. Patent Woes: Navigating the Perilous Waters of Intellectual Property Disputes - TipRanks

Oct 01, 2024
pulisher
Sep 30, 2024

Q32 Bio's SWOT analysis: emerging biotech stock targets inflammatory diseases - Investing.com India

Sep 30, 2024
pulisher
Sep 30, 2024

Q32 Bio's SWOT analysis: emerging biotech stock targets inflammatory diseases By Investing.com - Investing.com South Africa

Sep 30, 2024
pulisher
Sep 29, 2024

Sherwin-Williams (SHW) Set to Announce Quarterly Earnings on Monday - Defense World

Sep 29, 2024
pulisher
Sep 29, 2024

Ensign Peak Advisors Inc Purchases 38,750 Shares of Q32 Bio Inc. (NASDAQ:QTTB) - MarketBeat

Sep 29, 2024
pulisher
Sep 26, 2024

Bank of New York Mellon Corp Makes New $315,000 Investment in Q32 Bio Inc. (NASDAQ:QTTB) - MarketBeat

Sep 26, 2024
pulisher
Sep 23, 2024

Bruce K. Posey Sells 1,330 Shares of Qualys, Inc. (NASDAQ:QLYS) Stock - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

QXO (NASDAQ:QXO) Trading Up 4.7% - MarketBeat

Sep 23, 2024
pulisher
Sep 23, 2024

Q32 Bio (NASDAQ:QTTB) Trading Down 3.7% - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

Q32 Bio (NASDAQ:QTTB) Shares Down 3.7% - MarketBeat

Sep 23, 2024
pulisher
Sep 23, 2024

Stock Surge: Qualigen Therapeutics Inc (QLGN) Closes at 0.17, Marking a -4.84 Increase/Decrease - The Dwinnex

Sep 23, 2024
pulisher
Sep 22, 2024

Q32 Bio Inc.(NasdaqGM: QTTB) added to S&P Global BMI Index - Marketscreener.com

Sep 22, 2024
pulisher
Sep 22, 2024

Mutual of America Capital Management LLC Trims Stock Position in Qualys, Inc. (NASDAQ:QLYS) - Defense World

Sep 22, 2024
pulisher
Sep 21, 2024

Client First Investment Management LLC Purchases New Stake in ProShares Ultra QQQ (NYSEARCA:QLD) - Defense World

Sep 21, 2024
pulisher
Sep 20, 2024

Davidson Capital Management Inc. Boosts Holdings in Qualys, Inc. (NASDAQ:QLYS) - Defense World

Sep 20, 2024
pulisher
Sep 20, 2024

Inspire Investing LLC Acquires 2,595 Shares of Qualys, Inc. (NASDAQ:QLYS) - Defense World

Sep 20, 2024
pulisher
Sep 19, 2024

Choreo LLC Makes New $264,000 Investment in Qualys, Inc. (NASDAQ:QLYS) - Defense World

Sep 19, 2024
pulisher
Sep 19, 2024

Q32 Bio (NASDAQ:QTTB) Sees Strong Trading Volume - MarketBeat

Sep 19, 2024
pulisher
Sep 17, 2024

Q32 Bio (NASDAQ:QTTB) Trading 8.2% Higher - MarketBeat

Sep 17, 2024
pulisher
Sep 16, 2024

Harvard Management Co. Inc. Purchases New Stake in Q32 Bio Inc. (NASDAQ:QTTB) - MarketBeat

Sep 16, 2024
pulisher
Sep 14, 2024

Q32 Bio Inc. (NASDAQ:QTTB) Receives $68.80 Average PT from Analysts - Defense World

Sep 14, 2024
pulisher
Sep 14, 2024

EchoStar (NASDAQ:SATS) Hits New 12-Month High Following Analyst Upgrade - Defense World

Sep 14, 2024
$18.98
price up icon 3.66%
$76.97
price up icon 1.45%
$39.51
price up icon 7.22%
$359.21
price down icon 1.11%
$187.69
price down icon 0.81%
$101.87
price up icon 2.16%
Capitalizzazione:     |  Volume (24 ore):